A call to caution when hydroxychloroquine is given to elderly patients with COVID-19

INTRODUCTION: Use of hydroxychloroquine in patients with coronavirus disease 2019 (COVID-19) was widespread and uncontrolled until recently. Patients vulnerable to severe COVID-19 are at risk of hydroxychloroquine interactions with co-morbidities and co-medications contributing to detrimental, inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabor, Julian J., Kreidenweiss, Andrea, Weber, Stefan, Salama, Moaaz, Sulyok, Mihaly, Sulyok, Zita, Koehne, Erik, Esen, Meral, Kreuels, Benno, Shamsrizi, Parichehr, Biecker, Erwin, Mordmüller, Benjamin, Berg, Christoph P., Fusco, Stefano, Köhler, Carsten, Kubicka, Stefan, Leitlein, Jens, Addo, Marylyn, Ramharter, Michael, Schwab, Matthias, Bissinger, Alfred Lennart, Velavan, Thirumalaisamy P., Krishna, Sanjeev, Kremsner, Peter G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035801/
https://www.ncbi.nlm.nih.gov/pubmed/33848675
http://dx.doi.org/10.1016/j.ijid.2021.04.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035801/
https://www.ncbi.nlm.nih.gov/pubmed/33848675
http://dx.doi.org/10.1016/j.ijid.2021.04.009

Ejemplares similares